Jubilant Life Sciences seeks nod to roll out Remdesivir tablet

According to the proposal, the company is exploring the possibility of launching 20 mg sublingual tablets. Sublingual administration involves placing a drug under the tongue so that it gets dissolved and absorbed into the blood through the tissues.

from Industry-Economic Times https://ift.tt/34Uwhl9
via IFTTT